Hazer Group has published its fourth-quarter results for the 2025/26 financial year, detailing a significant strategic shift from laboratory-based hydrogen research to a commercial licensing model. The Perth-based clean energy firm, which has attracted interest from UK infrastructure investors, is now focusing on monetising its patented technology that produces hydrogen from natural gas while capturing solid carbon as a by-product.
The company’s Q4 update, released today, highlights progress in finalising licensing agreements with industrial partners. Hazer’s technology is seen as a potential enabler for the UK’s hydrogen economy, offering a lower-carbon route to hydrogen production without relying on electrolysis. The move to licensing reduces capital intensity for Hazer and could accelerate deployment in sectors such as steelmaking, chemicals, and heavy transport.
For UK investors, the shift reflects a broader trend in the clean energy sector: companies are moving from speculative R&D to revenue-generating models. While Hazer is not listed on the London Stock Exchange, its technology is relevant to several FTSE 350 companies exploring hydrogen supply chains. Analysts at Clean Energy Research noted that licensing deals could provide recurring revenue streams, though they cautioned that commercial-scale adoption remains dependent on government policy support and carbon pricing mechanisms.
The UK government has committed to 10GW of low-carbon hydrogen production capacity by 2030, with a mix of electrolytic and ‘blue’ hydrogen from natural gas with carbon capture. Hazer’s technology, which produces solid carbon rather than CO2, could fit into this framework if regulatory approval and cost competitiveness are achieved. The company’s Q4 results did not disclose specific revenue figures or signed licensing contracts, but management indicated that discussions with multiple international partners are at an advanced stage.
For UK pension holders with exposure to clean energy funds or infrastructure trusts, the development underscores the importance of tracking early-stage technology companies that may eventually supply the domestic hydrogen market. However, analysts warn that Hazer’s path to profitability is unproven, and investors should be aware of the risks inherent in pre-revenue technology firms.